Description:
ForusewithMultiplate®
Multiplate®HirudinBloodTube(Double-Wall)isabloodcollectiontubeforuseinplatelet aggregationstudieswiththeMultiplate®plateletfunction analyzertoevaluatequalitativeplateletdisordersat physiologicalcalciumconditions. Hirudin,athrombininhibitorallowsanticoagulationof bloodwithoutinterferencewithphysiologicalcalcium levels.
DuringtheearlyphaseofMultiplate®development,citratedblood(either3.2%or3.8%)was usedforthesamplecollection. Itwasobservedthatsubjectsdidnotaggregateproperly,particularlywithADPasagoNIST.Citratecomplexescalciumandtherebypreventsclottingofthesample.However,calciumisalsoanimportantsecondmessengerforplateletaggregation.Forafullshapechangeandfullexposureofreceptorsontheplateletsurface,thereleaseofcalciumfromtheintracellularstoresisnecessary.Thebestsolutionforthisproblemistouseananticoagulantwhichdoesnotaffectthefreecalciumconcentrationinthesample, ideallyhirudin(adirectthrombininhibitor).Heparinhassomeactivatingpropertiesonplatelets;therefore,theuseofhirudinbloodispreferred.Toreducetheinfluenceofcalciumdepletionbycitrate,apartialrecalcificationusingtheNaCl/CaCl2diluentsolution isused.ThepartialrecalcificationcanleadtoadisaggregationphenomenonintheASPItestandRISTOtest.Forthesetests,0.9% salineisusedwhentesting citratedblood.
Pleasenotethecatalog#forMultiplateHirudinVacuumBloodCollectionTubeshaschangedto08128812001.Youmayhavepreviouslyorderedthisproductundercatalog#MP0600or06675751001.
ForusewithT-TAS®plus
Composition:
Reagents,StorageandStABIlity
- 08128812001: Multiplate®HirudinBloodTube(Double-Wall),50x3.0mltubes,anticoagulant:recombinanthirudin
Nolongeravailable
- MP0601: Multiplate®HirudinBloodTube(Double-Wall),10x3.0mltubes,anticoagulant:recombinanthirudin
- MP0631: Multiplate®TI–ThrombinInhibitorBloodCollectionTube, 10x1.25mlmicrotubeswithscrewcap,anticoagulant:recombinanthirudin
Thespecifiedconcentrationofhirudinintheblood collectiontubesis>15µg/ml.Storetubesat4-25°C.Avoidexposuretodirectsunlight.
MeasurementPrinciple:
Refertopackageinsert.
DiapharmaCOVID-19血清学您与COVID-19相关的血栓形成和纤溶产品的资源对于基于人群的COVID-19研究和基本的SARS-CoV-2研究项目,COVID-19血清学测试是一种有价值的研究工具。这包括疫苗试验,治疗药物试验,流行病学研究和患病率分析。免疫学,传染病和凝血领域的COVID-19研究也可能发现SARS-CoV-2抗体检测有益和适用。产品方法/应用打包使用 ?目录 #Restalyst RAPIT COVID-19 lgM / lgG测试试剂盒横向流动色谱免疫分析25个设备/套件RURUOCL0100NS0Restalyst COVID19-REAAD™抗SARS-CoV-2 IgG ELISAELISA法试剂盒/ 96孔RURUOCE0200NS2Restalyst COVID19N-REAAD™抗SARS-CoV-2核衣壳蛋白IgG ELISAELISA法试剂盒/ 96孔RURUOCE0100NP1Technozym®抗SARS-CoV-2 RBD IgG ELISA试剂盒ELISA法试剂盒/ 96孔RU5600100Technozym®抗SARS-CoV-2 NP IgG ELISA试剂盒ELISA法试剂盒/ 96孔RU5600200金标准诊断SARS-CoV-2 IgG ELISA测试试剂盒ELISA法套件/ 96孔新冠肺炎GSD01-1028金标准诊断SARS-CoV-2 IgA ELISA检测试剂盒ELISA法套件/ 96孔新冠肺炎GSD01-1029

